Li X et al. |
20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616. |
2014 |
PLoS ONE |
pmid:24763529
|
Tse MM et al. |
Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. |
2013 May-Jun |
Vascul. Pharmacol. |
pmid:23466634
|
Eid S et al. |
Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. |
2013 Jul-Sep |
J. Biol. Regul. Homeost. Agents |
pmid:24152838
|
Imig JD |
Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23333581
|
Tunctan B et al. |
NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:22975359
|
Tunctan B et al. |
5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23454652
|
Ge Y et al. |
Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles. |
2013 Apr-May |
Prostaglandins Other Lipid Mediat. |
pmid:23500064
|
Kunduri SS et al. |
Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. |
2013 |
J. Cardiovasc. Pharmacol. |
pmid:23519140
|
Elshenawy OH et al. |
20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. |
2013 |
Curr. Drug Metab. |
pmid:23701160
|
Ma F et al. |
Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney. |
2013 |
Mol. Pharmacol. |
pmid:23729436
|